IQVIA (NYSE:IQV) Given New $165.00 Price Target at Barclays
IQVIA (NYSE:IQV – Free Report) had its price objective trimmed by Barclays from $170.00 to $165.00 in a research note published on Wednesday morning, Marketbeat.com reports. The firm currently has an equal weight rating on the medical research company’s stock. Several other equities analysts also recently weighed in on the company. UBS Group lowered their […]
IQVIA (NYSE:IQV – Free Report) had its price objective trimmed by Barclays from $170.00 to $165.00 in a research note published on Wednesday morning, Marketbeat.com reports. The firm currently has an equal weight rating on the medical research company’s stock. Several other equities analysts also recently weighed in on the company. UBS Group lowered their […]
